Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $6.52 USD
Change Today -0.15 / -2.25%
Volume 106.5K
TNXP On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - tonix pharmaceuticals holdin (TNXP)

Name (Connections)Board RelationshipsTitleKey Developments
Patrick Grace 31 RelationshipsDirector, Chairman of Audit Committee and Member of Governance & Nominating Committee 
John Rhodes 11 RelationshipsLead Director, Chairman of Governance & Nominating Committee and Member of Audit Committee 
Charles Mather IV, CFA 11 RelationshipsDirector, Member of Audit Committee and Member of Governance & Nominating Committee 

Compensation Committee* - tonix pharmaceuticals holdin (TNXP)

Name (Connections)Board RelationshipsTitle
Stuart Davidson 11 RelationshipsDirector and Chairman of Compensation Committee
Ernest Mario Ph.D. 288 RelationshipsDirector and Member of Compensation Committee
Samuel Saks M.D. 68 RelationshipsDirector and Member of Compensation Committee
TNXP Compensation vs. Industry
Not meaningful
Chief Executive Officer
185.4K
263.9K
Chief Financial Officer
Share price activity for TONIX PHARMACEUTICALS HOLDIN (TNXP)
52 Week Price Performance
TNXP
Industry Average

Nominating Committee* - tonix pharmaceuticals holdin (TNXP)

Name (Connections)Board RelationshipsTitleKey Developments
Patrick Grace 31 RelationshipsDirector, Chairman of Audit Committee and Member of Governance & Nominating CommitteeTonix Pharmaceuticals Holding Corp Announces Expiration of Employment Agreement with Donald Kellerman as Senior Vice President Clinical Development and Regulatory Affairs, Effective from March 31, 2015
01/16/15
John Rhodes 11 RelationshipsLead Director, Chairman of Governance & Nominating Committee and Member of Audit CommitteeTonix Pharmaceuticals Holding Corp. Appoints Ronald R. Notvest as Senior Vice President of Commercial Planning and Development
06/26/14
Charles Mather IV, CFA 11 RelationshipsDirector, Member of Audit Committee and Member of Governance & Nominating CommitteeTonix Pharmaceuticals Holding Corp. Appoints Gregory M. Sullivan as Chief Medical Officer
06/3/14

Corporate Governance Committee* - tonix pharmaceuticals holdin (TNXP)

Name (Connections)Board RelationshipsTitle
Patrick Grace 31 RelationshipsDirector and Chairman of Compensation Committee
Charles Mather IV, CFA 11 RelationshipsDirector and Member of Compensation Committee
John Rhodes 11 RelationshipsDirector and Member of Compensation Committee
TNXP and Competitor
Insiders vs. External
Board
17%
83%
Tonix Pharmaceuticals Holding Corp
Insiders
External Board Members

Advisory Committee* - tonix pharmaceuticals holdin (TNXP)

Name (Board Relationships)/Title Board Affiliations
Daniel Goodman 31 Relationships
Member of Scientific Advisory Board
No other board affiliations
Herbert Harris 11 Relationships
Member of Scientific Advisory Board
No other board affiliations
Iredell Iglehart 11 Relationships
Member of Scientific Advisory Board
No other board affiliations
Harvey Moldofsky 11 Relationships
Member of Scientific Advisory Board
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TNXP:US $6.52 USD -0.15

TNXP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TNXP.
View Industry Companies
 

Industry Analysis

TNXP

Industry Average

Valuation TNXP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 2.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TONIX PHARMACEUTICALS HOLDIN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.